Evolutionary Genomics Stock Buy Hold or Sell Recommendation
| FNAM Stock | USD 0.0002 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Evolutionary Genomics is 'Strong Sell'. The recommendation algorithm takes into account all of Evolutionary Genomics' available fundamental, technical, and predictive indicators you will find on this site.
Check out Evolutionary Genomics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Evolutionary and provide practical buy, sell, or hold advice based on investors' constraints. Evolutionary Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Evolutionary |
Execute Evolutionary Genomics Buy or Sell Advice
The Evolutionary recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Evolutionary Genomics. Macroaxis does not own or have any residual interests in Evolutionary Genomics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Evolutionary Genomics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Evolutionary Genomics Trading Alerts and Improvement Suggestions
| Evolutionary Genomics generated a negative expected return over the last 90 days | |
| Evolutionary Genomics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (2.79 M) with loss before overhead, payroll, taxes, and interest of (1.23 M). | |
| Evolutionary Genomics currently holds about 897.78 K in cash with (1.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 33.0% of the company shares are held by company insiders |
Evolutionary Genomics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Evolutionary Genomics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Evolutionary Genomics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Evolutionary pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Evolutionary Genomics Volatility Alert
At this time Evolutionary Genomics exhibits very low volatility. Evolutionary Genomics appears to be a penny stock. Although Evolutionary Genomics may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Evolutionary Genomics or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Evolutionary instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Evolutionary Genomics Fundamentals Vs Peers
Comparing Evolutionary Genomics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Evolutionary Genomics' direct or indirect competition across all of the common fundamentals between Evolutionary Genomics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Evolutionary Genomics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Evolutionary Genomics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Evolutionary Genomics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Evolutionary Genomics to competition |
| Fundamentals | Evolutionary Genomics | Peer Average |
| Return On Equity | -145.27 | -0.31 |
| Return On Asset | -0.45 | -0.14 |
| Current Valuation | 9.18 M | 16.62 B |
| Shares Outstanding | 6.66 M | 571.82 M |
| Shares Owned By Insiders | 32.60 % | 10.09 % |
| Price To Earning | (3.79) X | 28.72 X |
| Price To Sales | 352.91 X | 11.42 X |
| Gross Profit | (1.23 M) | 27.38 B |
| EBITDA | (1.84 M) | 3.9 B |
| Net Income | (2.79 M) | 570.98 M |
| Cash And Equivalents | 897.78 K | 2.7 B |
| Cash Per Share | 0.14 X | 5.01 X |
| Total Debt | 3.74 M | 5.32 B |
| Debt To Equity | 1.81 % | 48.70 % |
| Current Ratio | 9.85 X | 2.16 X |
| Book Value Per Share | (1.05) X | 1.93 K |
| Cash Flow From Operations | (1.58 M) | 971.22 M |
| Earnings Per Share | (0.53) X | 3.12 X |
| Number Of Employees | 2 | 18.84 K |
| Beta | -0.0153 | -0.15 |
| Market Capitalization | 4.66 M | 19.03 B |
| Total Asset | 2.93 M | 29.47 B |
| Retained Earnings | (1.33 M) | 9.33 B |
| Working Capital | (12.68 K) | 1.48 B |
| Current Asset | 991 | 9.34 B |
| Current Liabilities | 13.67 K | 7.9 B |
| Z Score | 0.6 | 8.72 |
| Net Asset | 2.93 M |
Evolutionary Genomics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Evolutionary . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 2.0E-4 | |||
| Day Typical Price | 2.0E-4 |
About Evolutionary Genomics Buy or Sell Advice
When is the right time to buy or sell Evolutionary Genomics? Buying financial instruments such as Evolutionary Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Evolutionary Genomics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Volatility ETFs Thematic Idea Now
Volatility ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Volatility ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Volatility ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Evolutionary Pink Sheet
Evolutionary Genomics financial ratios help investors to determine whether Evolutionary Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evolutionary with respect to the benefits of owning Evolutionary Genomics security.